Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cadila Healthcare has informed that post results Q&A session through teleconference has been scheduled on May 27, 2021 at 4:30 pm. Sharvil Patel, Managing Director of the Company would be hosting the call. The call will be conducted through the audio webcast format.
The above information is a part of company’s filings submitted to BSE.